MENLO PARK, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter ended April 1, 2016.
In the first quarter of 2016, total revenues and revenues before reimbursements grew by 4% year-over-year. Total revenues increased to $83,156,000 from $80,293,000 in the first quarter one year ago and revenues before reimbursements increased to $78,950,000 from $76,141,000 last year.
In the first quarter of 2016 Exponent early adopted a new accounting standard1 for the classification of tax adjustments associated with share-based awards, which was applied prospectively. The tax benefit realized was $4,461,000, or $0.16 per diluted share in the first quarter of 2016. Including the tax benefit, net income was $15,350,000 in the first quarter of 2016 as compared to $10,333,000 in the same period of 2015. For comparison purposes, excluding the tax benefit, net income would have been $10,889,000 in the first quarter, representing an increase of 5% year-over-year. Earnings per diluted share increased to $0.56, inclusive of the $0.16 per share benefit, as compared to $0.38 in the first quarter last year.
EBITDA2 increased by 3% to $18,998,000 as compared to $18,418,000 in the same period one year ago.
The Company repurchased $3.5 million of common stock, paid $4.6 million in dividends and ended the first quarter with $155 million in cash, cash equivalents and short-term investments. The Company continues an active stock repurchase program with $43.3 million currently authorized and available. In a separate release today, Exponent also announced a $0.18 quarterly dividend payment and reiterated its intent to continue to pay quarterly dividends.
“We are pleased to have grown revenues and earnings, despite the challenging year-over-year comparison due to the completion of a major project in the third quarter of 2015,” commented Dr. Paul Johnston, President and CEO. “We continued to be called upon to assist clients with a diverse set of product recalls ranging from vehicles to toys. We also supported clients in evaluating potential new products for performance, reliability, and safety. In the first quarter, we had notable performances from our materials, polymer science, electrical, thermal sciences, human factors and biomedical practices.”
“We are reiterating our expectations for 2016 and expect growth in revenues before reimbursements to be in the mid-single digits. We believe our underlying growth will be in the high single digits, but will be partially offset by the completion of a major project during the third quarter of 2015. As we previously discussed, we expect that 2016 EBITDA2 margin will decline approximately 50 to 100 basis points as compared to 2015, as a result of slightly lower utilization.”
“Exponent is retained to evaluate increasingly complex technologies, products, and processes as demand for both our reactive and proactive services continues to grow. We are optimistic about our opportunity to leverage our unique market position and we are confident in our ability to generate long-term growth and increase shareholder value," concluded Dr. Johnston.
Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, Wednesday, April 20, 2016, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (800) 768-6570 or (785) 830-1942. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (888) 203-1112 or (719) 457-0820, and entering passcode 8780649#.
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.
1 FASB Accounting Standard Update No. 2016-09, Improvements to Employee Share-Based Payment Accounting, March 30, 2016.
2 EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.
This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. When used in this document and in the documents incorporated herein by reference, the words “intend”, "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
|CONDENSED CONSOLIDATED STATEMENTS OF INCOME|
|For the Quarters Ended April 1, 2016 and April 3, 2015|
|(in thousands, except per share data)|
|April 1,||April 3,|
|Revenues before reimbursements||$||78,950||$||76,141|
|Compensation and related expenses||52,017||51,115|
|Other operating expenses||6,983||6,510|
|General and administrative expenses||3,514||3,488|
|Interest income, net||139||34|
|Miscellaneous income, net||1,159||2,009|
|Income before income taxes||17,734||17,071|
|Net income per share:|
|Shares used in per share computations:|
|CONDENSED CONSOLIDATED BALANCE SHEETS|
|April 1, 2016 and January 1, 2016|
|April 1,||January 1,|
|Cash and cash equivalents||$||98,535||$||125,751|
|Accounts receivable, net||94,912||88,577|
|Prepaid expenses and other assets||11,693||12,616|
|Total current assets||261,652||272,786|
|Property, equipment and leasehold improvements, net||28,465||28,485|
|Liabilities and Stockholders' Equity|
|Accounts payable and accrued liabilities||$||8,175||$||10,580|
|Accrued payroll and employee benefits||40,034||62,092|
|Total current liabilities||54,720||80,474|
|Additional paid-in capital||189,955||179,816|
|Accumulated other comprehensive loss||(1,725||)||(1,805||)|
|Treasury stock, at cost||(189,247||)||(184,499||)|
|Total stockholders' equity||272,540||262,804|
|EBITDA and EBITDAS (1)|
|For the Quarters Ended April 1, 2016 and April 3, 2015|
|April 1,||April 3,|
|Add back (subtract):|
|Interest income, net||(139||)||(34||)|
|Depreciation and amortization||1,403||1,381|
|(1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to compliment operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.|